ArticleBMC urology2025

Management of patients with lower urinary tract symptoms due to benign prostatic enlargement at risk of progression treated with 5-alpha-reductase inhibitors: examining real-world clinical practice in Spain and Brazil.

Juan Manuel Palacios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.